We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App





COVID-19 Patients Develop Fatal Blood Clots Due to High Alpha Defensin Protein Levels, Find Researchers

By HospiMedica International staff writers
Posted on 26 Jun 2020
Print article
Image: Prof. Higazi and lab manager Suhair Abdee (Photo courtesy of Hadassah-University Medical Center)
Image: Prof. Higazi and lab manager Suhair Abdee (Photo courtesy of Hadassah-University Medical Center)
Israeli researchers have identified the mechanism that causes a deadly COVID-19 complication that affects 30% of patients: the formation of large and small blood clots that create lethal blockages in the patient’s lungs, kidneys, heart, and brain.

Researchers from the Hadassah-University Medical Center (Jerusalem, Israel) have discovered that alpha-defensin, a peptide (an amino-acid chain) speeds up the creation of blood clots and prevents their disintegration. This finding is crucial in understanding what is happening to COVID-19 patients because existing anticoagulant drugs do not impact alpha-defensin.

A study of blood samples from patients in Hadassah’s COVID-19 Outbreak department found a high concentration of alpha-defensin. The researchers also found that the sicker the patient was, the higher the concentration of the peptide. The researchers are now working on a new way to dissolve the blood clots. They are testing colchicine, an oral medication used for gout and Familial Mediterranean fever. The drug has succeeded in reducing alpha-defensin levels and blood clots in mice, and the researchers are now awaiting approval to begin human trials. They believe that if the drug reduces blood clots in COVID-19 patients, it will vastly reduce the number of patients needing respirators.

“These patients have numerous blood clots in their lungs, preventing normative blood flow,” said Prof. Abd Al-Roof Higazi, head of the Hadassah Medical Organization’s Department of Clinical Biochemistry and Division of Laboratories. “We can give the drug to those with mild symptoms to prevent the development of blood clots.”

Related Links:
Hadassah-University Medical Center

Gold Supplier
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
New
Resting ECG Machine
CardiMax FX-8322
New
Double Shockwave Lithotripsy Machine
Duet Magna
New
Gold Supplier
Ultrasound Phantom
Multi-Purpose Multi-Tissue Ultrasound Phantom - Model 040GSE

Print article
Radcal

Channels

Critical Care

view channel
Image: An earbud prototype that has been wired for data collection (Photo courtesy of MUSC)

Earbuds to Outperform Smartwatches in Monitoring Blood Pressure

While blood pressure cuffs are considered the most accurate method of measurement, they require the user to sit down, put on the cuff, and stay still. This can be inconvenient and may lead to errors in... Read more

Surgical Techniques

view channel
Image: New robust thermosensitive bioadhesives can improve surgical sealing (Photo courtesy of Pexels)

New Surgical Sealing Biomaterial Could Eliminate Standard Methods of Suturing and Stapling

For surgical wounds to be properly closed, the sealant material used must effectively seal on wet, slippery tissue surfaces that vary in shape and may involve tissue movement, such as an expanding lung,... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Business

view channel
Image: The demand for endometrial ablation devices is increasing due to rising prevalence of gynecological disorders (Photo courtesy of Pexels)

Global Endometrial Ablation Market Driven by Rising Prevalence of Gynecological Disorders

Gynecological disorders, such as menorrhagia, PCOD, abnormal vaginal bleeding, affect millions of women globally every year and are on the rise. Abnormal Uterine Bleeding (AUB) is the most common disorder... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.